Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study

Novel and imminently emerging treatments in relapsing–remitting multiple sclerosis

(2015) Jiwon Oh et al.   CURRENT OPINION IN NEUROLOGY

Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice

(2013) Mark S. Freedman et al.   Multiple Sclerosis and Related Disorders

Low degree of cortical pathology is associated with benign course of multiple sclerosis

(2012) Massimiliano Calabrese et al.   Multiple Sclerosis Journal

‘Clinically definite benign multiple sclerosis’, an unwarranted conceptual hodgepodge: evidence from a 30-year observational study

(2012) E Leray et al.   Multiple Sclerosis Journal

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

(2009) G Comi et al.   LANCET

Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway

(2009) SB Glad et al.   Multiple Sclerosis Journal

Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis

(2009) E. Portaccio et al.   NEUROLOGY

Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis

(2008) C Hirst et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease

(2008) L Costelloe et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients

(2008) F G Joseph et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY